---
title: "Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% (sterile), 15 mL bot... — FDA record D-0661-2024 | Is It on Recall"
description: "Temperature abuse: Products exposed to improper temperature above drug label specifications."
url: https://isitonrecall.com/recall/fda-drug-d-0661-2024-proparacaine-hydrochloride-ophthalmic-solution-usp-0-5-sterile-15-ml-bottle-rx-only-mfg-bausch-lomb/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% (sterile), 15 mL bottle, Rx only, MFG: Bausch & Lomb, NDC 24... — FDA record D-0661-2024

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Sep 11, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% (sterile), 15 mL bottle, Rx only, MFG: Bausch & Lomb, NDC 24208-730-06
- **Reason**: Temperature abuse: Products exposed to improper temperature above drug label specifications.
- **Classification**: Class II
- **Recalling firm**: Mckesson Medical-Surgical Inc. Corporate Office
- **Quantity**: 27 bottles
- **Agency-reported status**: Terminated
- **Source record identifier**: D-0661-2024

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0661-2024%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot # 476261, 479751, 479741, Exp 3/31/2026 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

Product was distributed to two medical facilities in MD and VA.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Maryland](https://isitonrecall.com/state/maryland/)
- [Virginia](https://isitonrecall.com/state/virginia/)

## Dates in the source

- **Report date**: Oct 2, 2024
- **Recall initiation date**: Sep 11, 2024
- **Center classification date**: Sep 20, 2024
- **Termination date**: Jan 29, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0661-2024%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [Mckesson Medical-Surgical Inc. Corporate Office records](https://isitonrecall.com/brand/mckesson-medical-surgical-inc-corporate-office/)